This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Uconceive, A First-of-Its-Kind Conception Kit Designed To Address Both Male And Female Fertility Issues, Awarded U.S. Patent For Safe, Effective Conception Support

Uconceive integrates techniques for predicting ovulation, confirming ovulation, fertility-enhancing nutraceuticals for both the male and female partners, and also a method for confirming a successful conception. In addition, Uconceive is the only product of its kind that specifically addresses the two phases of the female's ovulation cycle separately.

In fact, Uconceive is so special and uniquely different from all other products on the market that it has been awarded a United States patent.

Whether you're trying to conceive, wanting to time your pregnancy, or having difficulty conceiving – Uconceive can help. Older couples with a "ticking" biological clock will also benefit.

Make Uconceive your first option for conception. Uconceive – making families, one baby at a time.

About the Uconceive development team:

Dr. Scott Sweazy is a board-certified Urologist and Fertility Specialist. In his practice, he performs numerous fertility-enhancing surgical procedures and counsels couples regarding their conception options.

Jill Sweazy has a PhD in health sciences and has worked in the pharmaceutical industry. She is the owner and President of Merriton Medical, LLC.

For more information go to:

For media inquiries contact Sam Hare at:(803) 603-6763 Email

This press release was issued through eReleases® Press Release Distribution. For more information, visit

SOURCE Uconceive

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,785.47 -13.02 -0.07%
S&P 500 2,089.12 -0.99 -0.05%
NASDAQ 5,119.1310 -8.3940 -0.16%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs